T1/ST2 is an immunoregulatory protein of the IL-1 receptor family that has recently been reported as being a component of the IL-33 receptor. IL-33 is a newly described cytokine known to amplify the Th2 response and reduce production of Th1 cytokines. The function of T1/ST2 during Toxoplasma gondii infection is as yet undescribed. Given the requirement of a balanced type 1/type 2 response for effective control of parasite number and immunopathology, it is likely that T1/ST2 may play a part in aiding this process. Accordingly, we have shown that T1/ST2 mRNA transcripts are upregulated in the brains of mice infected with T. gondii and that mice deficient in T1/ST2 demonstrated increased susceptibility to infection with T. gondii that correlated with increased pathology and greater parasite burden in the brains. Real-time PCR analysis of cerebral cytokine levels revealed increased mRNA levels of iNOS, IFN-c and TNF-a in infected T1/ST2 À/À mice. These effects were independent of changes in IL-10 production. This study provides the first evidence of a specific role for IL-33 receptor signalling in the brain as well as highlighting the requirement of this mechanism in limiting infection with an intracellular parasite.Key words: Encephalitis . IL-33 . IL-33 receptor . Th1/Th2 . Toxoplasma
IntroductionThe receptor T1/ST2 is a member of the IL-1 receptor family that also includes the TLR and the IL-18R [1]. Further characterisation revealed that differential splicing of T1/ST2 mRNA led to production of two different transcripts encoding either a transmembrane form (ST2L) or a soluble, secreted form (sST2) [2]. T1/ST2 is expressed by a number of haematopoetic cells such as T cells, mast cells, macrophages, NK cells and invariant NKT cells [3][4][5][6][7]. ST2L has previously been used as a marker for Th2 cells although T1/ST2-negative Th2 cells exist with reports that ST2L may be better described as a marker of effector Th2 cells enhancing the Th2 response rather than aiding its development [3,[8][9][10]. As well as promoting a Th2 response ST2L has been shown to sequester the signalling molecules MyD88 and Mal to inhibit subsequent cytokine production following TLR ligation [10]. sST2 also plays a role in downregulating the inflammatory response [6,11].
426T1/ST2 is the ligand-binding component of the receptor for the cytokine IL-33 which, together with the IL-1 receptor accessory protein, forms the IL-33 receptor [12,13]. IL-33 is a member of the IL-1 family with the ability to downregulate IFN-g production by Th1 cells in vitro and upregulate the production of the Th2 cytokines IL-5 and IL-13 from Th2 cells both in vitro and in vivo [12]. Therefore, the function of IL-33 reinforces the previously described role of T1/ST2 in enhancing a Th2 response while reducing a Th1 response.Protective immunity to the protozoan parasite Toxoplasma gondii relies on a delicate balance of type 1/type 2 immune responses to effectively control parasite proliferation and prevent pathology caused by an over-exuberant type-1 response [14]...